Get In Touch
  • According to Transparency Market Research’s latest report on the global antithrombin treatment market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of hereditary antithrombin deficiency to escalate the growth of global antithrombin treatment market. Moreover, adoption of new therapeutics is projected to drive the global antithrombin treatment market during the forecast period
  • According to the report, the global antithrombin treatment market was valued at US$ 0.50 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027

Request a sample to get extensive insights into the Antithrombin Market

Rise in Focus on Research & Rising Demand and Acceptance of Antithrombin Therapy: Key Drivers of Global Antithrombin Treatment Market

  • The acceptance of antithrombin in several medical conditions over conventional once is contribute to driving the demand for products and thereby drive the global antithrombin market.
  • Antithrombin is approved by FDA as anticoagulant and indicated in venous thromboembolic events in hereditary antithrombin deficient patients. Antithrombin also used in treatment of disseminated intravascular coagulation syndrome (DIC) and extracorporeal membrane oxygenation (ECMO), etc. Thus, gradual increase in prevalence of hereditary antithrombin deficiency leading to increase in the demand for the products and thereby drive the growth of market.
  • Key players are investing in research and development in order to develop new therapeutics to address the unmet needs. This in turn to drive the growth of the global antithrombin treatment market. For instance, China Biologic Products Holdings, Inc. integrated plasma-based biopharmaceutical company in China develop Human Antithrombin III for treatment of hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures and thromboembolism is in clinical trial phase III.

Technological Advancements Propel Global Antithrombin Treatment Market Growth

  • Technological advancements have helped bring down the total costs involved in production of therapeutic proteins. This has encouraged suppliers and manufacturers to seek newer avenues of therapeutic protein manufacturing and also to deal with longer and complex chains of peptides. Technological advancements in antithrombin is likely to boost the growth of the market in the near future

To understand how our report can bring difference to your business strategy, Ask for a brochure

Pricing Pressure to Hamper Global Antithrombin Treatment Market

  • Pricing is one of the concern over substitute and conventional anticoagulant therapy which could hamper growth of global antithrombin market. In many regions like Asia Pacific and Europe price concern hampers adoption of antithrombin therapy as there also pricing pressures, as antithrombin is seen as an expensive treatment with few returns.

Global Antithrombin Treatment Market: Competitive Landscape

  • This report profiles major players in the global antithrombin treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global antithrombin treatment market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global antithrombin treatment market are rEVO Biologics, Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee Bisolutions, Diapharma, Scripps Laboratories, Inc. and Other Prominent Companies

Stuck in a neck-to-neck competition with other brands? Request a custom report on Antithrombin Market

Global Antithrombin Treatment Market: Key Developments

Key players in the global antithrombin treatment market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global antithrombin treatment market. A few expansion strategies adopted by players operating in the global antithrombin treatment market are:

  • In September 2017, Kyowa Hakko Kirin Co., Ltd. received approval for additional formulation, ACOALAN injection 1800 IU
  • In August 2017, CSL Limited completed transaction to acquire a majority stake in China-based plasma fractionator, Wuhan Zhong Yuan Rui De Biological Products Co. Ltd.
  • In July 2017, CSL Ltd. announced launch of Haegarda (subcutaneous C1-INH, CSL830) in the U.S. approved for the treatment of hereditary angioedema (HAE) in patients
  • In January 2016, Octapharma announced launch of Nuwiq used in hemophilia patients to control bleeding, perioperative (surgical) management, and routine prophylaxis, in adults and children with hemophilia  A

The report on the global antithrombin treatment market discussed individual strategies, followed by company profiles of manufacturers of antithrombin products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global antithrombin treatment market.

Global Antithrombin Treatment Market - Scope of Report

TMR’s report on the global antithrombin treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global antithrombin treatment market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global antithrombin treatment market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global antithrombin treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global antithrombin treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global antithrombin treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global antithrombin treatment market.

The report delves into the competitive landscape of the global antithrombin treatment market. Key players operating in the global antithrombin treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global antithrombin treatment market that have been profiled in this report.

Key Questions Answered in Global Antithrombin Treatment Market Report

  • What is the scope of growth for product companies in the global antithrombin treatment market?
  • What will be the Y-o-Y growth of the global antithrombin treatment market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global antithrombin treatment market?
  • Will North America continue to be the most profitable market for antithrombin treatment providers?
  • Which factors are anticipated to hamper the growth of the global antithrombin treatment market during the forecast period?
  • Which are the leading companies in the global antithrombin treatment market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global antithrombin treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global antithrombin treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the antithrombin treatment market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the antithrombin treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global antithrombin treatment market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global antithrombin treatment more reliably and accurately.

Regional Segmentation of Antithrombin Treatment Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Global Antithrombin Treatment Market – Segmentation

Application

  • Therapeutic
  • Research
  • Diagnostics

Source

  • Human
  • Goat Milk
  • Others (Bovine, etc.)

Dosage Form

  • Lyophilized
  • Liquid

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Antithrombin Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Application Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global  Antithrombin Treatment Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis Globally: Snapshot

    5.3. Healthcare Industry Overview

6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        6.3.1. Therapeutic

        6.3.2. Research

        6.3.3. Diagnostics

    6.4. Global Antithrombin Treatment Market Attractiveness By Application

7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        7.3.1. Human

        7.3.2. Goat Milk

        7.3.3. Others (Bovine, etc.)

    7.4. Global Antithrombin Treatment Market Attractiveness By Source

8. Global  Antithrombin Treatment Analysis and Forecasts, By Dosage Form

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        8.3.1. Lyophilized

        8.3.2. Liquid

    8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form

9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Global Antithrombin Treatment Market Value  Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region

10. North America Antithrombin Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America  Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        10.2.1. Therapeutic

        10.2.2. Research

        10.2.3. Diagnostics

    10.3. North America  Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        10.3.1. Human

        10.3.2. Goat Milk

        10.3.3. Others (Bovine, etc.)

    10.4. North America  Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        10.4.1. Lyophilized

        10.4.2. Liquid

    10.5. North America  Antithrombin Treatment Market Value  Forecast By Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America  Antithrombin Treatment Market Attractiveness Analysis

        10.6.1. By Application

        10.6.2. By Source

        10.6.3. By Dosage Form

        10.6.4. By Country

11. Europe Antithrombin Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        11.2.1. Therapeutic

        11.2.2. Research

        11.2.3. Diagnostics

    11.3. Europe Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        11.3.1. Human

        11.3.2. Goat Milk

        11.3.3. Others (Bovine, etc.)

    11.4. Europe Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        11.4.1. Lyophilized

        11.4.2. Liquid

    11.5. Europe Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Antithrombin Treatment Market Attractiveness Analysis

        11.6.1. By Application

        11.6.2. By Source

        11.6.3. By Dosage Form

        11.6.4. By Country/Sub-region

12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        12.2.1. Therapeutic

        12.2.2. Research

        12.2.3. Diagnostics

    12.3. Asia Pacific Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        12.3.1. Human

        12.3.2. Goat Milk

        12.3.3. Others (Bovine, etc.)

    12.4. Asia Pacific Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        12.4.1. Lyophilized

        12.4.2. Liquid

    12.5. Asia Pacific Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis

        12.6.1. By Application

        12.6.2. By Source

        12.6.3. By Dosage Form

        12.6.4. By Country/Sub-region

13. Latin America Antithrombin Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        13.2.1. Therapeutic

        13.2.2. Research

        13.2.3. Diagnostics

    13.3. Latin America Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        13.3.1. Human

        13.3.2. Goat Milk

        13.3.3. Others (Bovine, etc.)

    13.4. Latin America Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        13.4.1. Lyophilized

        13.4.2. Liquid

    13.5. Latin America Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis

        13.6.1. By Application

        13.6.2. By Source

        13.6.3. By Dosage Form

        13.6.4. By Country/Sub-region

14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        14.2.1. Therapeutic

        14.2.2. Research

        14.2.3. Diagnostics

    14.3. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        14.3.1. Human

        14.3.2. Goat Milk

        14.3.3. Others (Bovine, etc.)

    14.4. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        14.4.1. Lyophilized

        14.4.2. Liquid

    14.5. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis

        14.6.1. By Application

        14.6.2. By Source

        14.6.3. By Dosage Form

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking By Company (2018)

    15.3. Company Profiles

        15.3.1. rEVO Biologics, Inc.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis.

        15.3.2. Grifols

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis.

        15.3.3. Shire plc.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis.

        15.3.4. CSL Limited

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis.

        15.3.5. Kedrion S.p.A

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis.

        15.3.6. Octapharma AG

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis.

        15.3.7. Dem ilac Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis.

        15.3.8. Lee Bisolutions

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis.

        15.3.9. Diapharma

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis.

        15.3.10. Scripps Laboratories, Inc.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis.

List of Table

Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 21: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 22: Middle East & Africa Size (US$ Mn) Forecast, by Source, 2017–2027

Table 23: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

List of Figure

Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2017–2027

Figure 02: Market Value Share, by Region 2018

Figure 03: Market Value Share, by Application 2018

Figure 04: Market Value Share, by Source 2018

Figure 05: Market Value Share, by Dosage Form 2018

Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2017–2027

Figure 09: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2017–2027

Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2017–2027

Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2017–2027

Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2017–2027

Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2017–2027

Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2017–2027

Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 30:North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 48:Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 58: Middle East & Africa Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 59: Middle East & Africa Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 60: Middle East & Africa Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 62: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 63: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 64: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 65: Heat Map Analysis By Company 2018

Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 67: Breakdown of Net Sales, by Business Segment, 2018

Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 69: Breakdown of Net Sales, by Business Segment, 2018

Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 71: Breakdown of Net Sales, by Region, 2018

Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 73: Breakdown of Net Sales by Business segments, 2018

Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Antithrombin Market